This document discusses the impact of consumable costs in healthcare, using clinical laboratories, pulse oximetry, bronchial thermoplasty, and temperature management systems as examples. It notes that consumable costs can often equal or exceed initial capital investments. It provides details on the types and pricing of consumables for different technologies and purchasing considerations for negotiating costs.
Concepte cheie din legislația specifică. Principalele obligații referitoare la prelucrarea datelor personale pe baza GDPR din mai 2018. Pașii pentru a ajunge spre respectarea legislației.
Prezentare susținută de Bogdan Manolea - Asociația pentru Tehnologie și Internet (ApTI - www.apti.ro), pe 7 noiembrie 2017, în cadrul Școlii Digitale pentru ONG-uri: ONG Online.
Școala Digitală pentru ONG-uri este un program anual creat de Asociația Techsoup pentru a ajuta angajați și voluntarii organizațiilor neguvernamentale din România și Republica Moldova să beneficieze de training profesionist și la îndemână online în utilizarea tehnologiei sau soluțiilor online disponibile lor. Mai multe pe https://ongonline.techsoup.ro/.
Concepte cheie din legislația specifică. Principalele obligații referitoare la prelucrarea datelor personale pe baza GDPR din mai 2018. Pașii pentru a ajunge spre respectarea legislației.
Prezentare susținută de Bogdan Manolea - Asociația pentru Tehnologie și Internet (ApTI - www.apti.ro), pe 7 noiembrie 2017, în cadrul Școlii Digitale pentru ONG-uri: ONG Online.
Școala Digitală pentru ONG-uri este un program anual creat de Asociația Techsoup pentru a ajuta angajați și voluntarii organizațiilor neguvernamentale din România și Republica Moldova să beneficieze de training profesionist și la îndemână online în utilizarea tehnologiei sau soluțiilor online disponibile lor. Mai multe pe https://ongonline.techsoup.ro/.
Reagents & reactions in estimation of pharmaceuticalsudaya rajitha
Reagents are used for the qualitative and quantitative determination of the pharmaceutical preparations, as they react with particular groups and increase their detectability by impart colour to the compounds.
Basic genetics /certified fixed orthodontic courses by Indian dental academy Indian dental academy
Welcome to Indian Dental Academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy has a unique training program & curriculum that provides students with exceptional clinical skills and enabling them to return to their office with high level confidence and start treating patients
State of the art comprehensive training-Faculty of world wide repute &Very affordable.
Acusera Third Party Quality Controls for Medical Laboratories Randox
With over 350 parameters available in our Acusera range, choice and flexibility is guaranteed. Moreover the availability of truly independent third party controls coupled with the added advantages of highly accurate target values, increased stability and unparalleled quality will optimise performance, save valuable time and minimise waste in any laboratory.
Our comprehensive range of multi-analyte controls have been uniquely developed with ease of use in mind, combining up to 100 parameters in one convenient control laboratories can significantly reduce the need for multiple, costly single analyte controls.
Consolidation
100% human controls for immunoassay purposes
Most accurate target values
Unrivalled stability
Most consistent controls
True third party controls
Randox QC offer an extensive range of third party quality controls. Manufactured independently, the Acusera range delivers unbiased performance assessment with any instrument or method, helping to meet ISO 15189:2012 requirements whilst simultaneously eliminating the need for multiple instrument dedicated controls.
Presentation: Clinical Evidence GuidelinesTGA Australia
This presentation provided an insight into the publication of the clinical evidence guidelines and an overview of clinical evidence requirements for medical devices. It also gave information about the level of clinical evidence required and the reason this level of evidence is required. Finally this presentation covered common errors made with clinical evidence.
Evolving Approaches to Measuring the Value of New Health Technologies in the USOffice of Health Economics
At this OHE Lunchtime Seminar, Dr Steven Pearson of the ICER organisation in the US discussed current US approaches to defining "value," compared these to NICE and discussed what changes may occur in the future.
https://www.slideshare.net/pragatimahajan3/supply-chain-and-inventory-part-2pptx
inventory control and supply chain
tender purchase procedure
quotation
prepration list of drug
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyWes Chapman
Transitioning to value based care in medical oncology is a major strategic change in any medical practice. In this presentation to Grand Rounds at the Norris Cotton Cancer Center at Dartmouth, we look at the strategic and operational considerations of making such a transition effective.
Reagents & reactions in estimation of pharmaceuticalsudaya rajitha
Reagents are used for the qualitative and quantitative determination of the pharmaceutical preparations, as they react with particular groups and increase their detectability by impart colour to the compounds.
Basic genetics /certified fixed orthodontic courses by Indian dental academy Indian dental academy
Welcome to Indian Dental Academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy has a unique training program & curriculum that provides students with exceptional clinical skills and enabling them to return to their office with high level confidence and start treating patients
State of the art comprehensive training-Faculty of world wide repute &Very affordable.
Acusera Third Party Quality Controls for Medical Laboratories Randox
With over 350 parameters available in our Acusera range, choice and flexibility is guaranteed. Moreover the availability of truly independent third party controls coupled with the added advantages of highly accurate target values, increased stability and unparalleled quality will optimise performance, save valuable time and minimise waste in any laboratory.
Our comprehensive range of multi-analyte controls have been uniquely developed with ease of use in mind, combining up to 100 parameters in one convenient control laboratories can significantly reduce the need for multiple, costly single analyte controls.
Consolidation
100% human controls for immunoassay purposes
Most accurate target values
Unrivalled stability
Most consistent controls
True third party controls
Randox QC offer an extensive range of third party quality controls. Manufactured independently, the Acusera range delivers unbiased performance assessment with any instrument or method, helping to meet ISO 15189:2012 requirements whilst simultaneously eliminating the need for multiple instrument dedicated controls.
Presentation: Clinical Evidence GuidelinesTGA Australia
This presentation provided an insight into the publication of the clinical evidence guidelines and an overview of clinical evidence requirements for medical devices. It also gave information about the level of clinical evidence required and the reason this level of evidence is required. Finally this presentation covered common errors made with clinical evidence.
Evolving Approaches to Measuring the Value of New Health Technologies in the USOffice of Health Economics
At this OHE Lunchtime Seminar, Dr Steven Pearson of the ICER organisation in the US discussed current US approaches to defining "value," compared these to NICE and discussed what changes may occur in the future.
https://www.slideshare.net/pragatimahajan3/supply-chain-and-inventory-part-2pptx
inventory control and supply chain
tender purchase procedure
quotation
prepration list of drug
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyWes Chapman
Transitioning to value based care in medical oncology is a major strategic change in any medical practice. In this presentation to Grand Rounds at the Norris Cotton Cancer Center at Dartmouth, we look at the strategic and operational considerations of making such a transition effective.
This Data for Impact webinar took place October 29, 2020. Learn more at https://www.data4impactproject.org/resources/webinars/use-of-routine-data-for-economic-evaluations/
Clinical documentation for medical devices Arete-Zoe, LLC
Clinical documentation for medical devices
Medical Devices Regulation (EU) 2017/745
We prepare EU MDR-compliant clinical documentation for medical device manufacturers for submission to notified bodies and national regulatory authorities.
EU MDR-compliant clinical documentation (English, Czech):
- Clinical evaluation (plan, report)
- Post-Market Clinical Follow-Up, -
- PMCF (plan, report, study design)
- Post-Market Surveillance System (plan, report)
- Clinical investigation design to complement existing evidence
- Biological Evaluation
- Literature review
Consulting
- Strategy how to generate clinical evidence
- Design of PMCF studies and clinical investigations
Additional support:
- Clinical expert for multiple medical specialties
- Risk management specialist
- Technical documentation
> Why HEOR?
> Costs, Consequences and Perspectives
> Key Stakeholders in HEOR
> What is Health Economics and Pharmaco-economic Research?
> Economic Evaluations
> Incremental Cost Effectiveness Ratio (ICER)
> Concept of HRQoL
> Comparative Effectiveness Research (CER)
> Pragmatic Clinical Trials
> Observational Studies
> Systematic Reviews and Meta-Analysis
> Application of CER
> Health Technology Assessment (HTA)
> Real World Evidence (RWE)
> Patient Reported Outcomes (PROs)
> Patient Focused Drug Development (PFDD)
> Application of Health Economic Evaluations
> Challenges and Barriers
Top 5 Trends from RSNA 2015 Day 1 | MD BuylineMD Buyline
Day 1 of RSNA 2015: Learn what the top trends were at the Radiological Society of North America (RSNA) annual meeting and scientific assembly for 2015; from the leader in healthcare supply chain management solutions, MD Buyline.
For the full article, visit http://www.mdbuyline.com/research-library/articles/top-5-trends-from-rsna-2015-day-1/.
Learn how Medtronic is replacing the 5388 and 5348 short-term pacemaker models by offering aggressive pricing coupled with rebates and trade-in values for the older external pulse generator devices.
For the full article, visit http://www.mdbuyline.com/blog/medtronic-external-pulse-generators-taking-advantage-rebate-trade-options./.
Five cost saving tactics for healthcare providers that lead to better outcomes on the income statement and individually can help providers with their bottom line, including reducing, reusing, refurbishing, reprocessing and reimbursement. For the full article, visit http://www.mdbuyline.com/blog/power-re/.
How prepared is your lab? Can it handle infectious diseases like Ebola? MD Buyline recommends certain instruments and pricing for point of care systems for bedside testing.
View the full article at http://www.mdbuyline.com/blog/contained-laboratory-ebola-infectious-disease-preparedness/.
NTI 2015 Day 1: Managing Drug Diversion, Non-Invasive Monitoring, Improving R...MD Buyline
Learn about the top trends from NTI 2015 Day 1 including three presentations that highlight the great work that can be achieved by empowering nursing staff to utilize various technologies through nurse-driven protocols and interventions; from the leader in healthcare supply chain management solutions, MD Buyline.
For the full article, visit http://www.mdbuyline.com/research-library/articles/top-trends-nti-2015-day-1/.
Streamlining the Hospital Supply Chain: Just What the Doctor Ordered | MD Buy...MD Buyline
As hospitals begin transforming to adapt to new healthcare initiatives, they are easing the pain by restructuring and streamlining supply chain operations. Learn how MD Buyline helps hospitals save money on purchased services and consumables in this feature, then visit www.mdbuyline.com for more information.
Sciencescape: Research Scientists Put a Twist on Social Media | MD BuylineMD Buyline
MD Buyline discusses Sciencescape, a research delivery and exploration service based in Canada which streams breaking scientific papers on over 50 million categories into a "Twitter" like tool. For more insights and medical device and technology research from MD Buyline, visit www.mdbuyline.com
Healthcare IT: The New Break-Even Analysis l MD BuylineMD Buyline
Mr. Laskaris, MD Buyline analyst, presented healthcare IT acquisition examples using the new break-even analysis at the Hospital Value Based Purchasing Summit.
Nurse Call - How Much Does a Nurse Call System Cost by Room? | MD MD Buyline
Find out how much a nurse call system costs hospitals by room. For more information on how MD Buyline helps hospitals save money with cost analysis, visit www.mdbuyline.com
Purchasers can often achieve savings from $117,000 to $140,500 off the vendor quotes for angiography systems. Savings can be considerably higher depending on the situation. Keys to success are creating a strong, united team approach, getting competitive bids and using a trusted resource to validate the financial and clinical status of your proposals.
Learn more about how MD Buyline helps hospitals save money on purchased services and consumables at www.mdbuyline.com
Hemodynamic and Physiological Monitoring Systems | MD BuylineMD Buyline
MD Buyline shares cost analysis and tips for negotiating competitive pricing on hemodynamic and physiological monitoring systems. For more information on how MD Buyline helps healthcare facilities save money by evaluating medical capital technology, visit www.mdbuyline.com
Pricing for Portable X Ray Units | MD BuylineMD Buyline
Pricing for portable X-ray systems varies, depending first on the technology segment (analog versus digital), then on the power rating of the unit’s chassis, and finally on the type and size of flat panel detector that is associated with the system. MD Buyline analyzes these systems and provides pricing analysis in this infographic. Learn more about how MD Buyline helps hospital systems save money at www.mdbuyline.com
The focus in the knee arthroplasty market is shifting toward personalized instrumentation, minimally invasive approaches, robotic assistance and implants designed for specific genders. Types of knee replacement procedures include total knee, partial knee (or knee resurfacing), and revisions with replacement components that include the femoral, tibial, and/or patella components. These components are designed to be cemented or non-cemented, and can include ceramic or non-ceramic inserts. Pricing for knee replacements shown below includes all components. Find more consumable benchmarks from MD Buyline at www.mdbuyline.com
Pricing for hip implants shown below includes all components, such as cemented and non-cemented, ceramic and non-ceramic. In the last couple of years, some of the focus has shifted to more personalized instrumentation, as well as a minimally invasive approach and robotic assistance. As with most consumable items, lower prices are usually achievable by standardizing on one vendor. Learn more about how MD Buyline helps hospitals with consumable price benchmarking, visit www.mdbuyline.com
Building the Case for Integrating the Surgical Services Suite l MD BuylineMD Buyline
In this presentation hosted by HFMA, clinical analysts from MD Buyline review the markets, technologies, costs, vendors, clinical outcomes, financial considerations and reimbursements for integrated ORs, hybrid ORs and intraoperative iMRI/iCT.
http://info.mdbuyline.com/l/18032/2013-11-12/d1hy9
Vendor Highlights from the AHRA 2014 Conference l MD BuylineMD Buyline
MD Buyline's clinical analyst Lori Webb highlights vendor showcases from the AHRA 2014 Conference in Washington, D.C. Learn about medical imaging solutions from Agfa Healthcare, Carestream Health, Canon, Del Medical, Fujifilm, GE, Konica Minolta, Kubtec, Samsung, Shimadzu, Siemens, Swissray and Toshiba.
http://www.mdbuyline.com/research-library/articles/2014-ahra-annual-meeting-exposition-vendor-highlights/
AHRA 2014 Annual Meeting l MD Buyline's Breakout Session: Transitioning to Di...MD Buyline
MD Buyline, the leader of healthcare supply chain management solutions, presented Transitioning to Digital Radiography at the AHRA 2014 Annual Meeting in Washington, DC.
http://www.mdbuyline.com/research-library/articles/transitioning-to-digital-radiography-2/
Part One: 2014 Changes to Reimbursement | MD Buyline | InfographicMD Buyline
In our report “Reimbursement Opportunities and Challenges in 2014,” we identify the key services and technologies hospitals should focus on to maximize CMS reimbursement payments.
For more information, visit mdbuyline.com
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
the IUA Administrative Board and General Assembly meeting
Medical Supplies Budgeting and Consumable Price Benchmarking l MD Buyline
1. Understanding the Impact of
Consumable Costs that Exceed
their Capital Investments
LeAnne Smith
Maria C. Hernandez, MBA, BSMT(ASCP)
Kathey Leibold, RRT
Lee Barnhart, RN
2. 2
Presenters
LeAnne Smith
Consumable Analyst, MD Buyline
– Joined MD Buyline in 2001
– Consumable team leader
– Previously served as Project
Manager at HELP
International
Maria C. Hernandez,
MBA, BSMT(ASCP)
Clinical Analyst, MD Buyline
– Joined MD Buyline in 2007
– 18 years in the clinical
healthcare field
– MT(ASCP) certified
– Member of American Society
of Clinical Pathologist
– Member of American
Association for Clinical
Chemistry
Kathey Leibold, RRT
Senior Clinical Analyst,
MD Buyline
– Joined MD Buyline in 2002
– Over 35 years in the clinical
healthcare field
– Registered Respiratory
Therapist
– Member of American
Association of Respiratory
Care and Texas Society for
Respiratory Care
Lee Barnhart, RN
Clinical Analyst, MD Buyline
– Joined MD Buyline in 2005
– 22 years in the nursing field
– Currently practicing RN
– Clinical Juror for the
Certification Commission on
Health Information
Technology (CCHIT)
– Member of Emergency
Nurses Association
3. 3
The Impact of Consumable Costs
• Projecting true costs for a new technology include considering:
– Capital
– Labor
• Outside of capital cost and labor, consumables present the next
largest line item for hospitals.
“In some instances, these [consumable] costs
may be equal to or even exceed the initial
capital outlay.”
Todd Nelson, HFMA Technical Director,
hfm magazine, August 2013
– Consumables
– Overhead
– Service
5. 5
Clinical Laboratory: Consumables
• Laboratory consumables have a different meaning than they do in the general
healthcare setting; it is important to understand the terminology used by
laboratory product vendors
– Lab consumables typically include
pipettes, slides, collections cups,
stirrer sticks, tubes, filters, tubing,
etc.
– Reagents, calibration and control
material are typically not grouped
with other consumable items
• Vendors may often exclude the
largest/most expensive portion of
the material needed to run the instruments
(reagents, calibration and control materials)
6. The Clinical Laboratory
6
Chemistry
Hematology
Microbiology
Coagulation
Blood Bank
Point of Care
Molecular
Genetics
Immunology
Source: Caris Life Sciences
7. • This profile is a routine test ordered by almost all healthcare providers
• A chemistry analyzer uses many reagents, consumables and quality
7
Clinical Laboratory: Chemistry Analyzer
in nearly all settings for determination of a patient’s health status
control (QC) material
Vendor Average Purchase Price*
*Source: MD Buyline
Procedures to
Breakeven
Vendor 1 $166,683 18,850
Vendor 2 $388,000 35,666
Vendor 3 $227,000 20,827
Vendor 4 $265,000 18,454
Vendor 5 $359,000 33,000
8. Discipline Capital Cost* Consumables Cost per year*
8
Clinical Laboratory: Consumable Cost
Core Lab
Discipline Capital Cost* Consumables Cost per year*
Hematology $301,100.00 for 3 analyzers $87,666.65
Chemistry $210,000.00 for 2 units $1,109,278.00
Molecular
$67,998.40
$494,274.31
Diagnostics
3 units and components
Glucometer
*Source: MD Buyline
$1,625,390.00
300 units and components
$2,092,424.70
Chemistry
$61,567.27
6 analyzers and components
$342,032.16
Point of Care
9. 9
Clinical Laboratory:
Purchasing Considerations
• Reducing consumable costs in the laboratory requires a unique
approach
• Most clinical laboratory setting vendors offer three types of purchasing
options:
– Direct Purchase
– Reagent Rental
– Cost per Reportable
10. 10
Purchasing Considerations:
Direct Purchase
• The facility outright owns the instrument and related accessories
– Purchase can be paid upfront or financed from a vendor or a third party lender
• Direct purchase scenarios are broken down by:
– Instrument(s)
– Service
– Reagents
– Consumables
– Financing fees (if any)
Pros
• Details facilitate negotiation
• Higher observed savings
• Negotiating future purchases
Cons
• Time intensive negotiation
• Upfront capital requirements
• Outdated equipment
12. – Vendors often tack on an upcharge for all reagents or consumables to
– Simple Rental
12
Purchasing Considerations:
Reagent Rental
• The instrument is “free” with the purchase of reagents
Pros
– Fair Market Value Lease
– $1 Buyout Lease
• Easier to budget for
• No upfront capital investment
• Updated equipment
Cons
• Difficult to negotiate pricing
• Penalties for decreased
reagent usage
compensate for lost revenue
• Reagent rentals can be priced as:
– Cost per Test
– Monthly Payment
• Reagent rental offers several types of pricing structures (simple,
moderate and complex)
13. 13
Reagent Rental Examples
• Types of pricing structures
– Simple pricing structure can be seen
in systems that require a kit to run a
test or panel of tests
– Moderate pricing structure is seen in
microbiology, molecular diagnostics,
hematology, and other esoteric areas
of the laboratory
14. 14
Reagent Rental Examples
– Complex pricing structures are seen in chemistry, immunoassay, special
chemistry and blood bank
15. 15
Purchasing Considerations:
Cost per Reportable
• Facility pays set price per patient result obtained using the instrument
• Cost of equipment and service typically rolled into the cost per test
• Often gives purchasers a false sense of low pricing
– A few cents difference here can mean the difference between hundreds of
thousands, if not millions, of dollars in additional costs to a facility
– Know what is rolled into the cost per reportable amount
Cons
• Itemization typically not given
• Difficult to negotiate pricing
• Difficult to compare quotes
• False sense of low pricing
• Penalties on Usage: Higher volumes
results in higher costs
• Pricing seldom easy to understand
Pros
• Easier to budget for
• No upfront capital necessary
• New Instrument at end of
contract
16. 16
Cost per Reportable Example
Reportable
Category
Price per
Reportable
Quantity per
Year
Annual Dollar
Amount
CMP $0.060 1,296,333 $77,779.98
Gen. Chemistry $0.096 438,811 $42,125.86
Esoteric $0.540 88,945 $48,030.30
TDM $1.620 25,993 $42,108.66
DAT $0.840 248,292 $208,565.28
Proteins $1.980 51,738 $102,441.24
Specialty $2.550 12,788 $32,609.40
Electrolyte $0.042 1,279,722 $53,748.32
Indices $0.018 430,355 $7,746.39
Minimum Annual Commitment: $615,155.43
17. Poll Question
What type of purchase option does your lab
typically utilize?
• Direct Purchase
• Reagent Rental
• Cost per Reportable
• A combination of two or three
• Don’t know
17
18. Respiratory: Pulse Oximetry
• Pulse oximetry offers a noninvasive measure of oxygen saturation of
18
arterial blood (SpO2)
• Considered part of the basic standard of care along with heart rate,
respiratory rate, blood pressure and temperature measurements
• Used over the continuum of care in areas such as:
– Critical care
– Emergency Department
– Labor & Delivery
– Surgery
– Post-Anesthesia Care Unit
– Central monitoring on post-surgical floors
– Recommended uniform screening panel
guidelines for newborns
Source: Schiller
19. 19
Pulse Oximetry: Types
• Handheld
– Lightweight without elaborate alarms or wave forms
– Designed for spot checking, short term or when a quick view of a SpO2 is needed
– Includes fingertip, wrist-worn and handheld models
• Bedside or Table-Top
– Most common type; ideal for continuous or long-term monitoring
• Multimodality
– Combines the measurement of additional parameters
– Examples: capnography, methemoglobin, carboxyhemoglobin, etc.
• Module
– Integrated into patient monitors, OR anesthesia monitors, defibrillators, infusion
pumps, portable vital sign units and mechanical ventilators
• Central or Remote Monitoring System
– Composed of a central station and bedside oximeters
– Utilized to monitor patients on a general care floor
– Hardwired or wireless RF systems
20. 20
Pulse Oximetry: Pricing by Type
Type of Pulse Oximeter Price Range*
Handheld
*Source: MD Buyline
Finger-tip: $300 - $600
Handheld: $1,200 - $4,000
Bedside or Table-Top $1,600 - $6,000
Multimodality An additional $2,000 - $6,000 on bedside pricing
depending on additional parameters
Module Physiological monitor module: $2,000 - $3,500
Infusion pump module: $3,400
Central or Remote Monitoring
System
$20,000 - $50,000, depending on bed
configurations
Additional cost for bedside pulse oximeters
22. 22
Pulse Oximetry: Sensor Types
• Single use disposable sensors
– Expensive
– Offer superior performance and accuracy
– Exert less pressure on the surface of the skin
– No risk of cross contamination
• Two piece sensors
– Lower cost
– Same performance of a single use sensor
– Small risk of cross contamination since cable is reused
• Reprocessed
– Cost per sensor is low
– Performance can be compromised
– No risk of cross contamination
• Reusable
– Cheapest and often most durable
– Low accuracy
– Possibility of cross contamination
23. Poll Question
What type of sensors are you mostly using at
your facility?
• Single use sensors
• Two piece sensors
• Reprocessed sensors
• Reusable sensors
• An even mix of two or more different sensors
23
25. • Patient body weight
• Skin integrity
• Perfusion
• Duration of monitoring
• Patient activity level
• Infection control concerns
25
Pulse Oximetry: Sensor Selection
26. • Competitive bids
• Market share commitments
– Provide good leverage to reduce sensor price
– Commitment level is negotiable and can be spread across multiple vendors
• Volume commitment
– Only useful for single use or reprocessed disposable sensors
– Volume of sensors should always be determined and set by the facility
– Ensure there is no price increase during the length of the term
– Vendor may agree to provide the equipment at no charge/reduced charge when
provider agrees to a set dollar amount in sensors
Determine upfront if the volume commitment required is sustainable
• Rebates
– Complex contracts that require a significant number of hours to ensure compliance
– We strongly discourage these type of contracts, if a vendor can afford to offer one
then it is likely that they can afford to reduce the cost of the sensors
26
Pulse Oximetry: Purchasing Considerations
27. Respiratory: Bronchial Thermoplasty
• Used to treat patients with severe asthma when it is not controlled well
27
by inhaled corticosteroids and long-acting beta agonists
• Currently, only one system is FDA approved
• System is comprised of:
– Controller unit
– Single patient use catheter
• Three disposable catheters are required for
each patient during a single treatment session
• Patients are treated through multiple sessions, targeting identified
areas of the lungs
Source: Asthmatx
28. Respiratory: Bronchial Thermoplasty
28
Pricing for Vendor 1*
Bronchial Thermoplasty Controller
Min: $48,999
Max: $59,999
Average: $56,384
Single Use Catheter
Min: $2,500
Max: $2,500
Average: $2,500
*Source: MD Buyline
• At $7,500 per treatment, the cost of the consumable catheters
exceeds the price of the system ($48,999) after 6.5 treatments
• Typical consumable cost overall per patient treated ~$22,500
29. • Bundle programs
– Associated with consumable agreement offering a discounted price
for the system with a commitment to purchase a set volume of
catheters
29
Bronchial Thermoplasty:
Purchasing Considerations
30. Poll Question
Is your facility currently offering bronchial
thermoplasty treatment?
• Yes
• No
• Unsure
30
31. • Temperature management systems are widely used as a
neuroprotectant and cardioprotectant
• Need for temperature management systems is expected to grow in the
next ten years
• Studies continue to validate the significant clinical impact of
temperature regulation and induced (therapeutic) hypothermia
31
Nursing: Temperature Management
Therapeutic hypothermia is most often used to lower a patient’s
body temperature in order to help reduce the risk of ischemic
injury to tissue following a period of insufficient blood flow.
32. • Strong clinical evidence for use in cardiac arrest patients, those
suffering from hemorrhagic shock and several forms of severe brain
injury
• Several major U.S. cities require ambulances to transport cardiac
arrest patients only to hospitals with hypothermia capabilities
• Temperature management is recognized as part of the standard of
care for critically ill or surgical patients by:
32
Temperature Management :
Clinical Evidence
33. Temperature Management : System Types
• Strong
33
Temperature
Management Systems
Differences
Endovascular/Intravascular
Requires physician involvement
Potential for bleeding complication
Studies indicate a more rapid cooling rate
Surface Management
Accomplished by nursing personnel, quick to apply
Potential for skin burns
Two types: conductive and convective
34. Poll Question
What type of temperature management
systems are you using at your facility?
• Endovascular/Intravascular
• Surface Management
• Don’t currently use any temperature
management system
• Don’t know
34
35. • The outcome for both types of temperature management systems is
related to reducing mortality and providing better neurological
outcomes at discharge
• This can be considered a soft dollar reimbursement
– Clinical evidence associated with temperature management shows a direct
correlation with improved outcome and recovery
– This can be linked with a reduced length of stay and complications
– This offers a financial benefit to hospitals through the Affordable Care Act
Hospitals are measured by the quality of care they provide related to decreasing
“never events” and hospital readmission
35
Temperature Management:
Soft Dollar Considerations
36. 36
Temperature Management:
Pricing by Vendor
Endovascular Surface Management
Vendor Price Range*
Vendor 1 $34,436 - $34,856
Vendor 2 $33,372 - $40,639
*Source: MD Buyline
Vendor Price Range*
Vendor 1 $12,355 - $14,535
Vendor 3 $38,000 - $41,000
Vendor 4 $6,950
Vendor 5 $4,500 - $4,795
*Source: MD Buyline
• Price differences between high and low end systems based on:
– Graphical user interfaces
– Color displays
– Type of data tracked and trended over time
37. • Careful patient selection is critical to help control cost since items are
single patient uses
• Clinical evidence suggests patients who should potentially be
excluded from using the devices include these characteristics:
– Greater than 6 hours after cardiac arrest
– Major head trauma
– Major surgery within 14 days
– Systemic infections
– Patients with ongoing bleeding
– Patients in a coma from other causes (e.g., drug intoxication)
• By limiting patient selection to those patients that have shown benefit
from induced hypothermia, hospitals are able to control costs
37
Temperature Management:
Other Financial Considerations
38. 38
Temperature Management:
Consumable Cost
Vendor Description Average Price*
Vendor 1
Catheter A triple lumen $858
Catheter B triple lumen $750
Catheter C triple lumen $550
Vendor 2 Catheter A single lumen $1,322
Vendor Description Average Price*
Vendor 2
Flow channels for water
circulation
$595
Vendor 3
Hydrogel coating mimic water
immersion
$1,122
Vendor 4 Water circulation $300
Vendor 5 Water circulation $308
*Source: MD Buyline
Catheters
Surface Products
39. 39
Temperature Management:
Purchasing Considerations
• Catheters and surface products are vendor specific
• Vendors do not typically offer pricing discounts based on committed
volume or market share
– Consumable items are routinely left off purchasing contracts
• Best practice: Negotiate consumable costs at the time of capital
purchase
– This is when you have the most negotiating power
– Lock in pricing for at least three years
• Large hospital systems using more than one device should negotiate
jointly for consumables if possible
40. • Cardiac ablation is used to correct heart rhythm
disorders, often when medicine is not effective or
appropriate
• Ablation uses two different types of energy to
destroy diseased or damaged tissue in the body
– Radiofrequency (RF)
Utilizes heat, which is created from radio waves is the most
commonly used ablation technique in cardiac indications
Energy is a low-voltage, high-frequency form of electrical energy
– Cryo
Utilizes extreme cold, which is produced by a coolant, such as argon or nitrous oxide
• Ablation affects cells closet to the catheter tip, which results in scar
tissue, this disrupts the electrical current, and, in most cases, causes
the heart to return to a natural rhythm
40
Cardiology: Cardiac Ablation
Source: The Mayo Foundation
41. Poll Question
Which type of energy are you using for your
cardiac ablation procedures?
• Radiofrequency
• Cryo
• Don't know
41
42. • Atrial fibrillation (AFib) is the most common heart rhythm disorder treated
with cardiac ablation, leading to blood clots, stroke, heart failure or other
complications
• Cardioversion is the first line of treatment, followed by ablation
– Recent prospective randomized trials have indicated that catheter ablation might
offer better outcomes over traditional anti-arrhythmic medications for some patients
• In 2010, European Society of Cardiology guidance supported the use of
catheter ablation without first attempting anti-arrhythmic drugs
• Soft dollar considerations:
- Improved outcomes can now be linked to soft dollar considerations under
the Affordable Care Act
- Current clinical evidence suggests cardiac ablation can decrease the
likelihood of recurrence in patients anywhere from 44-87%
42
Cardiology: Cardiac Ablation
43. 43
Cardiology: Pricing of Generator
Vendor Generator Price*
Vendor 1 Cryo Based System: $7,000
Vendor 2
RF Based System: $25,000
Cryo Based System A: $17,500
Cryo Based System B: $170,000
Vendor 3 RF Based System: $33,000
*Source: MD Buyline
44. 44
Cardiology: Probe / Catheter Cost
Vendor Probe / Catheter Cost*
Cost for 20
Procedures/Year*
Cost over Life of
Generator*
(assumed 7 years)
Vendor 1 Cryo Probe – $2,995 - $3,000 $59,900 $419,300
Vendor 2
RF Probes – $1,695 - $3,495
Cryo Probe A – $2,795 - $2,900
Cryo Probe B – $1,700 - $4,800
$33,900 - $69,900
$55,900 - $58,000
$34,000 - $96,000
$237,300 - $489,300
$391,300 - $406,000
$238,000 - $672,000
Vendor 3 RF Probe – $650 - $1,500 $13,000 - $30,000 $91,000 - $210,000
*Source: MD Buyline
• There are no third party sources for supplying the catheters
• Once you purchase a generator, you are essentially locked in to purchasing
the consumables from the specific vendor
45. Cardiac Ablation: Purchasing Considerations
45
• Two different types of purchase options:
– Outright purchase of the capital equipment
– Capital equipment offered at no charge, based on an annual
commitment of catheter or probe purchases
Negotiate consumable costs prior to purchasing the generator
Ensure catheter or probe cost is clear from the beginning
Remember: Consumables are tied to vendors, there are no third
party options
• We recommend considering the outright purchase of the capital
equipment
46. Conclusion: Understanding your Purchase
46
• There are commonalities with regards to cost management, purchase
negotiation, facility considerations, and hurdles across ALL departments:
o Choose the Equipment that is right for your facility
o Determine your annual procedure volumes
o Choose the length of the agreement that best fits your facility
o Know your expected cost increases
o Ask Questions before you agree to anything